BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36417142)

  • 1. Is It Really Gone? Assessing Response to Neoadjuvant Therapy in Rectal Cancer.
    Kimura C; Crowder SE; Kin C
    J Gastrointest Cancer; 2023 Sep; 54(3):703-711. PubMed ID: 36417142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer.
    Santiago I; Barata M; Figueiredo N; Parés O; Henriques V; Galzerano A; Carvalho C; Matos C; Heald RJ
    Eur Radiol; 2020 Jan; 30(1):224-238. PubMed ID: 31350587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
    Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
    [No Abstract]   [Full Text] [Related]  

  • 4. Complete Response Evaluation of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy Using Textural Features Obtained from T2 Weighted Imaging and ADC Maps.
    Azamat S; Karaman Ş; Azamat IF; Ertaş G; Kulle CB; Keskin M; Sakin RND; Bakır B; Oral EN; Kartal MG
    Curr Med Imaging; 2022; 18(10):1061-1069. PubMed ID: 35240976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy.
    Shin J; Seo N; Baek SE; Son NH; Lim JS; Kim NK; Koom WS; Kim S
    Radiology; 2022 May; 303(2):351-358. PubMed ID: 35133200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How reliable is restaging MRI after neoadjuvant therapy in rectal cancer?
    Gefen R; Garoufalia Z; Horesh N; Freund MR; Emile SH; Parlade A; Berho M; Allende D; DaSilva G; Wexner SD
    Colorectal Dis; 2023 Aug; 25(8):1631-1637. PubMed ID: 37376824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal Assessments Are Needed for Restaging after Neoadjunvant Chemoradiation Therapy in Rectal Cancer Patients.
    Kye BH; Kim HJ; Kim G; Kim JG; Cho HM
    Cancer Res Treat; 2016 Apr; 48(2):561-6. PubMed ID: 26323642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restaging MRI of Rectal Adenocarcinoma after Neoadjuvant Chemoradiotherapy: Imaging Findings and Potential Pitfalls.
    Awiwi MO; Kaur H; Ernst R; Rauch GM; Morani AC; Stanietzky N; Palmquist SM; Salem UI
    Radiographics; 2023 Apr; 43(4):e220135. PubMed ID: 36927125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR Imaging of Rectal Cancer: Radiomics Analysis to Assess Treatment Response after Neoadjuvant Therapy.
    Horvat N; Veeraraghavan H; Khan M; Blazic I; Zheng J; Capanu M; Sala E; Garcia-Aguilar J; Gollub MJ; Petkovska I
    Radiology; 2018 Jun; 287(3):833-843. PubMed ID: 29514017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of magnetic resonance in "non-operative treatment" strategy for rectal cancer].
    Wang Y; Chen G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):630-634. PubMed ID: 28643307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of MRI and endoscopy for assessing complete response in rectal cancer after neoadjuvant chemoradiotherapy: a systematic review of the literature.
    Munk NE; Bondeven P; Pedersen BG
    Acta Radiol; 2023 Jan; 64(1):20-31. PubMed ID: 34928715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study.
    Feng L; Liu Z; Li C; Li Z; Lou X; Shao L; Wang Y; Huang Y; Chen H; Pang X; Liu S; He F; Zheng J; Meng X; Xie P; Yang G; Ding Y; Wei M; Yun J; Hung MC; Zhou W; Wahl DR; Lan P; Tian J; Wan X
    Lancet Digit Health; 2022 Jan; 4(1):e8-e17. PubMed ID: 34952679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development.
    Chiloiro G; Cusumano D; de Franco P; Lenkowicz J; Boldrini L; Carano D; Barbaro B; Corvari B; Dinapoli N; Giraffa M; Meldolesi E; Manfredi R; Valentini V; Gambacorta MA
    Radiol Med; 2022 Jan; 127(1):11-20. PubMed ID: 34725772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Tumor Response Between Flexible Sigmoidoscopy and Magnetic Resonance Imaging in Patients Undergoing Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Retrospective Review.
    Rojas MA; Cataneo J; Gagnon-Konamna M; Borsuk DJ; Jarzabek AJ; Marecik SJ; Park JJ; Kochar K
    Am Surg; 2023 Jun; 89(6):2595-2599. PubMed ID: 35617529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI assessment of rectal cancer response to neoadjuvant therapy: a multireader study.
    Yuval JB; Patil S; Gangai N; Omer DM; Akselrod DG; Fung A; Harmath CB; Kampalath R; Krehbiel K; Lee S; Liu PS; Millet JD; O'Malley RB; Purysko AS; Veniero JC; Wasnik AP; Garcia-Aguilar J; Gollub MJ
    Eur Radiol; 2023 Aug; 33(8):5761-5768. PubMed ID: 36814032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
    Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Pattern-Based Approach Combining Tumor Morphology on MRI With Distinct Signal Patterns on Diffusion-Weighted Imaging to Assess Response of Rectal Tumors After Chemoradiotherapy.
    Lambregts DMJ; Delli Pizzi A; Lahaye MJ; van Griethuysen JJM; Maas M; Beets GL; Bakers FCH; Beets-Tan RGH
    Dis Colon Rectum; 2018 Mar; 61(3):328-337. PubMed ID: 29369900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application value of colonoscopic assessment in "watch and wait" strategy for mid-lower rectal cancer after neoadjuvant chemoradiotherapy].
    Li SJ; Wang L; Zhang XY; Li YH; Li ZW; Wu Q; Sun YS; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul; 22(7):648-655. PubMed ID: 31302963
    [No Abstract]   [Full Text] [Related]  

  • 19. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
    Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
    Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer.
    Gollub MJ; Blazic I; Felder S; Knezevic A; Gonen M; Garcia-Aguilar J; Paty PP; Smith JJ
    Eur Radiol; 2019 Mar; 29(3):1104-1113. PubMed ID: 30242504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.